|
|
|
|
|
|
| Current General Counsel and Corporate Secretary Christopher L. Gaenzle to assume new leadership role; move demonstrates Company's enhanced focus on support areas of the organization essential to success |
Raleigh, N.C., Aug 28, 2013 - (ACN Newswire) - INC Research LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced the appointment of Christopher L. Gaenzle to the newly created role of Chief Administrative Officer (CAO), further rounding out the Company's executive leadership team. The creation of the CAO role is designed to enhance INC's focus on key initiatives related to the development and deployment of a best-in-class workforce, supporting the Company's strategy for continued growth and expansion as a top-tier CRO. Mr. Gaenzle, who joined INC Research in April 2012 as General Counsel and Corporate Secretary, will continue to serve in this capacity in addition to assuming the CAO role, through which he will provide global leadership for such key functions as Human Resources, Training and Corporate Quality.
"As we move forward and position INC Research to compete for the larger strategic outsourcing opportunities, our infrastructure and ability to deliver on a global scale have never been more important," said CEO Jamie Macdonald. "The creation of the CAO role provides an enhanced focus on the support areas of our organization essential to our future success. We look forward to Chris' leadership as we continue to drive growth and meet the strategic outsourcing needs of our customers worldwide."
As General Counsel for INC Research, Mr. Gaenzle has been responsible for the Company's legal affairs for the U.S. and internationally, and advises the Board of Directors, the CEO and the executive team on legal matters. In addition, Mr. Gaenzle oversees INC's Corporate Quality and compliance functions. With the addition of the CAO role, he also will provide overall leadership for the Human Resources, Training and Facilities functions. Mr. Gaenzle has nearly 20 years of private practice and corporate legal experience, the majority in the pharmaceutical, medical and clinical research industries. Prior to joining INC he was Assistant General Counsel at Pfizer Inc. He brings to the CAO role valuable experience gained at Pfizer where his responsibilities included operational support and talent management at a functional level.
The creation of the CAO role and the appointment of Mr. Gaenzle complement other executive leadership moves at INC Research in recent months, including the appointments of Greg Rush as Executive Vice President and CFO and Ian Braithwaite, PhD, as Executive Vice President and General Manager, General Medicine.
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to us for a complete range of customized Phase I to IV programs in all therapeutic areas and patient populations. Our Trusted Process(R) methodology and therapeutic foresight lead customers to better-informed product development decisions, while our solid site relationships are a critical success factor in delivering clinical trial results on time and on budget. INC was ranked "Top CRO" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
Contact:
Lori Dorer, Media +1-513-345-1685
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
Topic: Executive appointment
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
